Alain Francina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alain Francina has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Philippe Lacan
Unité de Pathologie Moléculaire, Fédération de Biochimie et de Biologie Spécialisée, Hôpital Edouard Herriot, Lyon, France
16 shared publications Martine Aubry
Unité de Pathologie Moléculaire du Globule Rouge, Fédération de Biochimie et de Biologie Spécialisée, Hôpital Edouard-Herriot (HCL), Lyon, France
12 shared publicationsNicole Couprie
Laboratoire Biomnis, Avenue Tony Garnier, Lyon, France
10 shared publicationsPhilippe Lacan
Unité de Pathologie Moléculaire du Globule Rouge, Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
7 shared publicationsCaroline Garcia
Unité de Pathologie Moléculaire du Globule Rouge, Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
6 shared publicationsPhilippe Joly
Unité de Pathologie Moléculaire du Globule Rouge, Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
6 shared publications
Latest Publications
- 10 October 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 38 (1) , 64-66
Description of the Phenotypes of 63 Heterozygous, Homozygous and Compound Heterozygous Patients Carrying the Hb Groene Hart [α119(H2)Pro→Ser;HBA1: c.358C>T] Variant
We here report the phenotypes and genotypes of 63 patients of North African origin, carriers of Hb Groene Hart [Hb GH, α119(H2)Pro → Ser; HBA1: c.358C>T], an α+-thalassemia (α+-thal) hemoglobin (Hb) variant. Fifty patients were heterozygous, five were homozygous and eight also carried the common −α3.7 (rightward) deletion in compound heterozygosity. The expression of the αGH-globin chain is increased in the following order: heterozygous, compound heterozygous and homozygous. Parallel significant changes of mean corpuscular Hb (MCH) and mean corpuscular volume (MCV) were also observed. Our large cohort of Hb GH carriers could have been obtained by the systematic realization of globin chain separation by reversed phase liquid chromatography (RP-LC) in our routine Hb testing.
- 10 October 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 38 (1) , 64-66
Description of the Phenotypes of 63 Heterozygous, Homozygous and Compound Heterozygous Patients Carrying the Hb Groene Hart [α119(H2)Pro→Ser;HBA1: c.358C>T] Variant
We here report the phenotypes and genotypes of 63 patients of North African origin, carriers of Hb Groene Hart [Hb GH, α119(H2)Pro → Ser; HBA1: c.358C>T], an α+-thalassemia (α+-thal) hemoglobin (Hb) variant. Fifty patients were heterozygous, five were homozygous and eight also carried the common −α3.7 (rightward) deletion in compound heterozygosity. The expression of the αGH-globin chain is increased in the following order: heterozygous, compound heterozygous and homozygous. Parallel significant changes of mean corpuscular Hb (MCH) and mean corpuscular volume (MCV) were also observed. Our large cohort of Hb GH carriers could have been obtained by the systematic realization of globin chain separation by reversed phase liquid chromatography (RP-LC) in our routine Hb testing.
- 27 June 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 37 (5) , 486-491
Two Complex Associations of anHBDMutation and a RareαHemoglobinopathy
We present two case reports in which an HBD mutation is present with a rare α hemoglobinopathy that substantially complicates the associated phenotype. In the first case, a new δ-globin variant, Hb A2-Pierre-Bénite [δ83(EF7)Gly→Arg; HBD: c.250G>C] is associated with Hb Groene Hart [α119(H2)Pro→Ser (α1); HBA1: c.358C>T], an α-thalassemic variant. In the second case, a δ+-thalassemic variant, δ4(A1)Thr→Ile; HBD: c.14C>T, is associated with a newly described deletion of the hypersensitive site 40 (HS-40) region on the α-globin gene cluster. In both patients, a δ-globin mutation was suspected because of an abnormally low Hb A2 level, whereas the α hemoglobinopathy was sought to explain the slight microcytosis and hypochromia presented by the probands.
- 27 June 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 37 (5) , 486-491
Two Complex Associations of anHBDMutation and a RareαHemoglobinopathy
We present two case reports in which an HBD mutation is present with a rare α hemoglobinopathy that substantially complicates the associated phenotype. In the first case, a new δ-globin variant, Hb A2-Pierre-Bénite [δ83(EF7)Gly→Arg; HBD: c.250G>C] is associated with Hb Groene Hart [α119(H2)Pro→Ser (α1); HBA1: c.358C>T], an α-thalassemic variant. In the second case, a δ+-thalassemic variant, δ4(A1)Thr→Ile; HBD: c.14C>T, is associated with a newly described deletion of the hypersensitive site 40 (HS-40) region on the α-globin gene cluster. In both patients, a δ-globin mutation was suspected because of an abnormally low Hb A2 level, whereas the α hemoglobinopathy was sought to explain the slight microcytosis and hypochromia presented by the probands.
- 7 September 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 415, 35-40
Characterization of three new deletions in the β-globin gene cluster during a screening survey in two French urban areas
- 7 September 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 415, 35-40
Characterization of three new deletions in the β-globin gene cluster during a screening survey in two French urban areas
- 1 June 2012
- Published by Taylor & Francis in Hemoglobin
- Vol. 36 (5) , 508-510
A New Frameshift Mutation on theα2-Globin Gene Causingα+-Thalassemia: Codon 43 (TTC>–TC or TTC>T–C)
We report a new mutation on the α2-globin gene causing α+-thalassemia (α+-thal) with a deletion of a single nucleotide (T) at amino acid residue 43 [HBA2:c.130delT or HBA2:c.131delT]. This frameshift deletion gives rise to a premature termination codon at codon 47.
- 1 June 2012
- Published by Taylor & Francis in Hemoglobin
- Vol. 36 (5) , 508-510
A New Frameshift Mutation on theα2-Globin Gene Causingα+-Thalassemia: Codon 43 (TTC>–TC or TTC>T–C)
We report a new mutation on the α2-globin gene causing α+-thalassemia (α+-thal) with a deletion of a single nucleotide (T) at amino acid residue 43 [HBA2:c.130delT or HBA2:c.131delT]. This frameshift deletion gives rise to a premature termination codon at codon 47.
- 25 October 2011
- Published by Elsevier in Journal of Chromatography B
- Vol. 883-884, 172-176
Protein characterization by LC–MS/MS may be required for the DNA identification of a fusion hemoglobin: The example of Hb P-Nilotic
- 25 October 2011
- Published by Elsevier in Journal of Chromatography B
- Vol. 883-884, 172-176
Protein characterization by LC–MS/MS may be required for the DNA identification of a fusion hemoglobin: The example of Hb P-Nilotic
- 28 July 2011
- Published by Taylor & Francis in Hemoglobin
- Vol. 35 (4) , 316-322
A Novel Deletion/Insertion Caused by a Replication Error in the β-Globin Gene Locus Control Region
Deletions in the β-globin locus control region (β-LCR) lead to (εγδβ)0-thalassemia [(εγδβ)0-thal]. In patients suffering from these rare deletions, a normal hemoglobin (Hb), phenotype is found, contrasting with a hematological thalassemic phenotype. Multiplex-ligation probe amplification (MLPA) is an efficient tool to detect β-LCR deletions combined with long-range polymerase chain reaction (PCR) and DNA sequencing to pinpoint deletion breakpoints. We present here a novel 11,155 bp β-LCR deletion found in a French Caucasian patient which removes DNase I hypersensitive site 2 (HS2) to HS4 of the β-LCR. Interestingly, a 197 bp insertion of two inverted sequences issued from the HS2-HS3 inter-region is present and suggests a complex rearrangement during replication. Carriers of this type of thalassemia can be misdiagnosed as an α-thal trait. Consequently, a complete α- and β-globin gene cluster analysis is required to prevent a potentially damaging misdiagnosis in genetic counselling.
- 28 July 2011
- Published by Taylor & Francis in Hemoglobin
- Vol. 35 (4) , 316-322
A Novel Deletion/Insertion Caused by a Replication Error in the β-Globin Gene Locus Control Region
Deletions in the β-globin locus control region (β-LCR) lead to (εγδβ)0-thalassemia [(εγδβ)0-thal]. In patients suffering from these rare deletions, a normal hemoglobin (Hb), phenotype is found, contrasting with a hematological thalassemic phenotype. Multiplex-ligation probe amplification (MLPA) is an efficient tool to detect β-LCR deletions combined with long-range polymerase chain reaction (PCR) and DNA sequencing to pinpoint deletion breakpoints. We present here a novel 11,155 bp β-LCR deletion found in a French Caucasian patient which removes DNase I hypersensitive site 2 (HS2) to HS4 of the β-LCR. Interestingly, a 197 bp insertion of two inverted sequences issued from the HS2-HS3 inter-region is present and suggests a complex rearrangement during replication. Carriers of this type of thalassemia can be misdiagnosed as an α-thal trait. Consequently, a complete α- and β-globin gene cluster analysis is required to prevent a potentially damaging misdiagnosis in genetic counselling.
- 11 June 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (13-14) , 1257-1261
Rapid and reliable β-globin gene cluster haplotyping of sickle cell disease patients by FRET Light Cycler and HRM assays
- 11 June 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (13-14) , 1257-1261
Rapid and reliable β-globin gene cluster haplotyping of sickle cell disease patients by FRET Light Cycler and HRM assays
- 31 January 2010
- Published by Elsevier in Clinical Biochemistry
- Vol. 43 (1-2) , 193-197
Rapid genotyping of two common G6PD variants, African (A-) and Mediterranean, by high-resolution melting analysis
- 31 January 2010
- Published by Elsevier in Clinical Biochemistry
- Vol. 43 (1-2) , 193-197
Rapid genotyping of two common G6PD variants, African (A-) and Mediterranean, by high-resolution melting analysis
- 30 November 2009
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (5) , 850-851
A novel telomeric ( 285 kb) -thalassemia deletion leading to a phenotypically unusual HbH disease
Many large deletions removing the entire α-globin gene cluster on the short arm of the human chromosome 16 (16p13.3) have been described.[1][1]–[3][2] At the heterozygous state, the resulting phenotype consists in α-thalassemia (α-thal) for relatively short deletions (100 to 356 kb) while an
- 30 November 2009
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (5) , 850-851
A novel telomeric ( 285 kb) -thalassemia deletion leading to a phenotypically unusual HbH disease
Many large deletions removing the entire α-globin gene cluster on the short arm of the human chromosome 16 (16p13.3) have been described.[1][1]–[3][2] At the heterozygous state, the resulting phenotype consists in α-thalassemia (α-thal) for relatively short deletions (100 to 356 kb) while an
- 4 May 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (18) , 1807-1817
Phenotype determination of hemoglobinopathies by mass spectrometry
- 4 May 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (18) , 1807-1817
Phenotype determination of hemoglobinopathies by mass spectrometry